Meningoencephalitis
Showing 1 - 25 of 133
Neurocognitive Impairment in Pediatric Meningoencephalitis and
Active, not recruiting
- Critical Illness
- +5 more
-
Rostock, GermanyUniversity Medical Center Rostock
May 17, 2022
Oxidative Stress in West Nile Virus Infection
Withdrawn
- West Nile Virus
- +8 more
-
Bucharest, RomaniaVictor Babes Hospital
Feb 9, 2021
Encephalitis, Meningitis, Meningoencephalitis Trial in China (Types of etiological diagnostic methods)
Recruiting
- Encephalitis
- +4 more
- Types of etiological diagnostic methods
-
Nanjing, Jiangsu, China
- +6 more
Jun 29, 2021
Meningitis Streptococcal, Hiv, Meningitis Trial in Ho Chi Minh City (Tamoxifen, Amphotericin B, Fluconazole)
Completed
- Meningitis Streptococcal
- +3 more
- Tamoxifen
- +2 more
-
Ho Chi Minh City, Vietnam
- +2 more
Nov 28, 2019
Vaccine Responsiveness in Allergy, Vaccine Responsiveness During Allergy De-sensitization Treatment Trial in Vienna (TBE booster
Completed
- Vaccine Responsiveness in Allergy
- Vaccine Responsiveness During Allergy De-sensitization Treatment
- TBE booster vaccination
-
Vienna, AustriaMedical University Vienna, Institute of Specific Prophylaxis and
Oct 3, 2019
Epidemic Meningitis Trial (MCV4)
Not yet recruiting
- Epidemic Meningitis
- MCV4
- (no location specified)
Jul 5, 2023
Clinical Characteristics and Long-term Outcomes of Brucellosis
Completed
- Brucellosis
-
Huanggang, Hu Bei Province, China
- +7 more
Aug 17, 2023
Assess Clinical Outcomes of Complement Factor I
Terminated
- Recurrent Bacterial Infection, Autoimmune Disorder
- Natural History Observation
-
Huntsville, AlabamaNephrology Consultants, LLC
Mar 31, 2022
CNS Infections, CNS Complication, Infectious Disease of Nervous System Trial in Worldwide
Recruiting
- Central Nervous System Infections
- +5 more
-
Westmead, Australia
- +16 more
Jun 1, 2022
Research for Angiostrongylus Cantonensis and Costaricensis in
Recruiting
- Angiostrongylosis
- Hypereosinophilia
- Parasitic serologies
- Biopsy
-
Fort-de-France, FranceCHU of Martinique
Dec 10, 2020
Post-intensive Care Syndrome, Transitional Care, Critical Care Trial in Pittsburgh (PICTURE-THIS, Enhanced Usual Care, Run-In
Recruiting
- Post-intensive Care Syndrome
- +3 more
- PICTURE-THIS
- +2 more
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh
Oct 10, 2023
Chikungunya Virus Infection Trial in United States (VLA1553, Placebo)
Completed
- Chikungunya Virus Infection
- VLA1553
- Placebo
-
Chandler, Arizona
- +43 more
Jul 25, 2022
SARS-COV2 (COVID-19) Persistence After Convalescence
Recruiting
- COVID-19
- +2 more
-
New York, New YorkColumbia University Medical Center
Jul 19, 2022
Study of Febrile Syndromes After Tick Bite
Recruiting
- Febrile Syndrome
-
Strasbourg, FranceService Laboratoire de Bactériologie - Hôpitaux Universitaires d
Nov 18, 2021
Cognitive Impairment and Neuropsychiatric Manifestations of
Completed
- Brucellosis
- MoCA
-
Mansoura, EgyptMansoura University Hospital
Mar 16, 2020
Biomarker Study for Alzheimer's Disease
Completed
- Alzheimer's Disease
- Blood sample
-
Beersheva, IsraelBeersheva Mental Health Center
Jan 26, 2021
Shifts in Respiratory Microbiome and Clinical Outcomes of
Terminated
- SARS-CoV-2 Infection
- +2 more
-
Delaware, Ohio
- +3 more
Jun 25, 2021
Aseptic Meningoencephalitis in Slovenia
Unknown status
- Aseptic Meningitis
- symptomatic therapy
- +3 more
-
Ljubljana, Slovenia
- +1 more
May 3, 2018
Virus in Central Nervous System
Recruiting
- COVID-19 Testing
- +2 more
- Determination of SARS-CoV2 presence in CNS
-
Milan, ItalyIRCCS San Raffaele Scientific Institute
Feb 27, 2021
Cryptococcosis, Cryptococcal Infections, AIDS-Related Opportunistic Infections Trial in Kampala (Sertraline, Placebo Oral
Terminated
- Cryptococcosis
- +2 more
- Sertraline
- +2 more
-
Kampala, UgandaInfectious Disease Institute, Makerere University
Jun 2, 2020
Bladder Cancer Trial in Worldwide (Atezolizumab)
Active, not recruiting
- Bladder Cancer
-
Birmingham, Alabama
- +76 more
Dec 6, 2022
Relapsing Multiple Sclerosis (RMS) Trial in United States (Ublituximab, Teriflunomide, Oral Placebo)
Completed
- Relapsing Multiple Sclerosis (RMS)
- Ublituximab
- +3 more
-
Carlsbad, California
- +13 more
Nov 5, 2021
COVID-19 Trial in Worldwide (Dapagliflozin 10 milligram (mg), Placebo)
Completed
- COVID-19
- Dapagliflozin 10 milligram (mg)
- Placebo
-
Fairhope, Alabama
- +94 more
May 13, 2022